Cardio Diagnostics Holdings Inc (CDIO) FinancialsCDIOFinancialCardio Diagnostics Holdings Inc

Evaluating the bottom line, Cardio Diagnostics Holdings Inc maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -27950.50%, while the net margin is -28012.46%. These profitability ratios, combined with a Return on Equity (ROE) of -75.44%, provide a clear picture of how effectively CDIO converts its operational activities into shareholder value.

In the context of the broader market, CDIO competes directly with industry leaders such as ITOC and AMIX. With a market capitalization of $6.01M, it holds a significant position in the sector. When comparing efficiency, CDIO's gross margin of 100.00% stands against ITOC's 79.03% and AMIX's N/A. Such benchmarking helps identify whether Cardio Diagnostics Holdings Inc is trading at a premium or discount relative to its financial performance.

The company has shown fluctuating revenues, with a Q2 2026 revenue of 5,360, which is a decrease from previous quarters. The gross margin remains strong at 100%, but the net income has consistently been negative, indicating ongoing financial struggles.